N/A
N=28
Vivo Prediabetes Study: Online, Live, and Interactive Strength Training for Older Adults With Prediabetes
PreDiabetes · Older Adults · Muscle Loss · Muscle Weakness
Bottom Line
View on ClinicalTrials.gov: NCT05497960 ↗Enrolled (actual)
28
Serious AEs
0.0%
Results posted
Nov 2024
Primary outcome: Primary: Leg Strength Assessed Through a 30 Second Chair Rise Test — 14.2 number of chair stands
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Vivo workout (Behavioral)
- Age
- Adult, Older Adult · 60+ yrs
- Sex
- All
- Sponsor
- Eric Levian
- Primary completion
- Mar 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Leg Strength Assessed Through a 30 Second Chair Rise Test |
14.2 | — |
| PRIMARY Workout Attendance |
85 | — |
| PRIMARY Intervention Engagement Assessed by Self- Reported Ease of Use |
82; 86; 95 | — |
| PRIMARY Program Satisfaction |
95 | — |
| PRIMARY Exercise Intervention Trainer Fidelity Checklist |
96 | — |
Summary
This research trial studies the effect of an online, live and interactive strength training program on physical function and strength in older adults with prediabetes.
Eligibility Criteria
Inclusion Criteria
- Age ≥ 60 years;
- Diagnosis of Pre-diabetes within prior 12 months: fasting glucose between 100 to 126 OR HbA1c between 5.7 and 6.4%
- Ambulatory and community-dwelling
- Sedentary: less than 150 minutes of moderate physical activity OR less than 75 minutes of vigorous physical activity per week
- Have not engaged in resistance training for at least 6 months prior to enrollment
- Low functioning (defined as able to do at least 1 chair stand without using hand in 30 second but unable to meet the moderate function criteria for age and gender)
- Access to WiFi (or internet connection) in defined exercise space
- Willing to maintain weight and current diet throughout the study
Exclusion Criteria
- Inability to complete physical function assessment or inability to do a chair stand without using hands.
- Use of antidiabetic medications
- Use of testosterone supplement or replacement
- Clinical disorder precluding/interfering with participation or assessments
- Unstable angina, arrhythmia, uncontrolled hypertension
- End Stage Renal Disease on Hemodialysis
- Lower extremity amputation or paralysis
- Neurological conditions causing functional or pronounced cognitive impairments
- Active malignancy except for non-melanomatous skin cancers
- Unable to provide consent
- Weight instability
Data sourced from ClinicalTrials.gov (NCT05497960). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.